1. Home
  2. GFR vs CMPX Comparison

GFR vs CMPX Comparison

Compare GFR & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenfire Resources Ltd.

GFR

Greenfire Resources Ltd.

HOLD

Current Price

$5.89

Market Cap

790.2M

Sector

N/A

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$2.07

Market Cap

927.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GFR
CMPX
Founded
2018
2014
Country
Canada
United States
Employees
197
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
790.2M
927.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GFR
CMPX
Price
$5.89
$2.07
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$14.57
AVG Volume (30 Days)
164.5K
5.2M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$934.41
P/E Ratio
$4.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.10
$1.61
52 Week High
$7.02
$6.88

Technical Indicators

Market Signals
Indicator
GFR
CMPX
Relative Strength Index (RSI) 47.27 37.58
Support Level $5.62 $1.68
Resistance Level $6.29 $3.82
Average True Range (ATR) 0.24 0.17
MACD -0.02 0.16
Stochastic Oscillator 37.04 46.66

Price Performance

Historical Comparison
GFR
CMPX

About GFR Greenfire Resources Ltd.

Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations. The company is actively developing its Hangingstone Facilities using SAGD, an enhanced oil recovery extraction method.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: